Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $31 to $33.
Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $31 to $33.